These effects, along with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the concept of concentrating on ACKR3 as a novel strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Diseases. Disclaimer: The above is https://conolidineisnotanopioid77542.webbuzzfeed.com/33335884/the-conolidine-diaries